News within Clinical Medicine
Professor Dermot O'Toole elected Chairman of ENETS
Neuroendocrine tumors (NETs) present numerous complex clinical problems. Due to their relatively rare occurrence, research and patient care guidelines since the 1990s have been lacking. As a result, the European Neuroendocrine Tumor Society was founded in 2004 and the society members, currently numbering nearly 1,200, bring a variety of expertise from such fields as oncology, pathology, radiology, nuclear medicine, endocrinology, surgery and gastroenterology to ENETS. Professor O'Toole was elected chairman in March 2017 during the ENETS Annual General Assembly Meeting,
Professor O'Toole is Professor in Gastroenterology and Clinical Medicine at Trinity College Dublin and is Consultant Gastroenterologist in St James's Hospital Dublin and the Neuroendocrine Tumour specialist in the ENETS accredited European Centre of Excellence in St Vincent's University Hospitals Dublin.
His major research interest is in gastrointestinal cancer biology especially focussing in neuroendocrine-related diseases and early neoplasia in the gastrointestinal tract (Barrett's oesophagus, gastric and colorectal cancers).
Professor O'Toole leads the national endoscopic interventional program for early digestive cancers and is also national clinical lead for the neuroendocrine tumour group. He also serves on the executive committee of the European Neuroendocrine Tumours Society (ENETS) and has helped develop many guidelines, papers and standards of care initiatives in the field of NET as well as chairing the ENETS-driven European Centre of Excellence program. He has been principal investigator and/or coordinator in many national and international research activities in GI oncology.